Lead Opinion
I
{¶ 1} The common-law collateral-source rule generally prevents the admission of evidence in a tort action showing payments made to benefit the plaintiff from any source other than the tortfeasor. The General Assembly largely abrogated the common-law rule by enacting R.C. 2315.20. This case asks us to determine the effect of R.C. 2315.20 on our holding in Robinson v. Bates,
II
{¶ 2} The plaintiff-appellee, Richard Jaques, was involved in an auto accident with the defendant-appellant, Patricia Mantón. Jaques brought a personal-injury action against Mantón to recover for injuries he sustained in the accident. Mantón admitted liability, leaving only causation and damages to be determined at the jury trial.
{¶ 3} Jaques received treatment from various medical providers for his injuries. The total amount billed for those services amounted to $21,874.80. The medical treatment was covered by Jaques’s insurance policy with Medical Mutual of Ohio, which did not pay the full amount billed. The providers instead accepted reduced payments totaling $7,483.91 as payment in full pursuant to their agreements with Medical Mutual.
{¶ 4} Before trial, the trial court sustained Jaques’s motion to preclude Mantón from offering evidence of the $14,390.89 in write-offs by the medical providers. At trial, the jury was able to consider only the amount billed by the medical
Ill
{¶ 5} A plaintiff is entitled to recover reasonable medical expenses incurred for injuries caused by the tortious conduct of a defendant. Robinson v. Bates,
{¶ 6} The court of appeals relied on R.C. 2315.20 in holding that evidence of write-offs is inadmissible. That statute provides: “In any tort action, the defendant may introduce evidence of any amount payable as a benefit to the plaintiff as a result of the damages that result from an injury, death, or loss to person or property that is the subject of the claim upon which the action is based, except if the source of collateral benefits has * * * a contractual right of subrogation * *
{¶ 7} Our decision in Robinson,
{¶ 8} We observed in Robinson that “[b]ecause no one pays the write-off, it cannot possibly constitute payment of any benefit from a collateral source.” (Emphasis sic.) Id. at ¶ 16. Permitting a tortfeasor to introduce evidence of write-offs does not violate the purpose of the common-law rule, because the tortfeasor is not benefiting from actual payments by third parties. Id. The common-law rule does not, therefore, preclude introducing evidence of write-offs. Id.
{¶ 9} The general rule enacted in R.C. 2315.20 is contrary to the common-law collateral-source rule. The General Assembly has expressly established that evidence of collateral benefits is admissible. The statute does include exceptions, however, including when the source of the payment has a contractual right of subrogation. It is undisputed that Medical Mutual has a contractual right of subrogation to recover from the proceeds of Jaques’s personal-injury claim the amount it paid to benefit Jaques.
{¶ 10} The subrogation exception will generally prevent defendants from offering evidence of insurance coverage for a plaintiffs injury, because insurance agreements generally include a right of subrogation. The defendant would then be liable for the full cost of the plaintiffs medical expenses, even though those expenses have been paid by insurance. The plaintiff does not receive a windfall payment, however, because the insurer has subrogation rights to recover any expenses it has already paid. This appropriately leaves the burden of medical expenses on the tortfeasor. If there is no right of subrogation, then any recovery for expenses paid by a third party that have benefitted the plaintiff would remain with the plaintiff, resulting in a windfall.
{¶ 11} Jaques argues that R.C. 2315.20, not Robinson, controls in this case and that the statute compels us to hold that evidence of write-offs is no longer admissible. We disagree. The general collateral-source rule in R.C. 2315.20 must apply before the subrogation exception of the statute can apply. The general rule pertains only to “evidence of any amount payable as a benefit to the plaintiff.” This formulation is no different substantively from the common-law rule described in Robinson,
{¶ 12} Both versions of the collateral-source rule are concerned with actual payments made by third parties to the benefit of the plaintiff, but the focus of the
{¶ 13} Jaques argues that R.C. 2315.20 does apply to write-offs, because write-offs are evidence of a payment to the plaintiff, even though they are not payments themselves. If a jury knows both the gross amount billed by a medical provider and the amount by which that provider agreed to reduce the bill, Jaques contends, the jury will deduce that the plaintiff had insurance coverage and apply simple subtraction to determine the collateral benefit. The jury thus, Jaques argues, obtains the evidence that R.C. 2315.20 expressly prohibits, when, like the insurer here, the insurer has a right of subrogation.
{¶ 14} While Jaques’s concerns may not be unfounded, we see no indication of those concerns in the language of the statute. We are required to apply the plain language of a statute when it is clear and unambiguous. State v. Lowe,
{¶ 15} Because R.C. 2315.20 does not prohibit evidence of write-offs, the admissibility of such evidence is determined under the Rules of Evidence. A plaintiff is entitled to recover the reasonable value of medical expenses incurred due to the defendant’s conduct. Robinson at ¶ 7, 17, citing Wagner,
IV
{¶ 16} The trial court and court of appeals both erred in refusing to admit evidence of write-offs by medical providers relating to Jacques's care R.C.
Judgment reversed and cause remanded.
Dissenting Opinion
dissenting.
{¶ 17} The statute at issue in this case is extraordinarily straightforward and the issue before us exceedingly simple. The court of appeals adequately covered the issue in 11 short paragraphs, yet it takes the majority opinion 16 long paragraphs to confuse the issue and obfuscate the law.
{¶ 18} R.C. 2315.20(A) states, “In any tort action, the defendant may introduce evidence of any amount payable as a benefit to the plaintiff * * * except if the source of collateral benefits has a * * * contractual right of subrogation * *
{¶ 19} At issue in this case is whether a defendant may introduce evidence of a write-off. In this case, Jaques was billed $21,874.80 for medical expenses. The medical provider accepted $7,483.91 as payment in full, writing off $14,390.89. Jaques understandably wants the jury to think that he incurred $21,874.80 in medical expenses; Mantón understandably wants the jury to think that Jaques incurred only $7,483.91 in medical expenses.
{¶ 20} R.C. 2315.20(A) answers the question before us: evidence of the amount payable may not be introduced, because “the source of collateral benefits has a * * * contractual right of subrogation.” Jaques did not negotiate the write-off; neither did Mantón. The provider of Jaques’s medical care did not initiate the lesser payment. Who is left to be the source of the collateral benefits? It can only be Jaques’s insurance company. It initiated and negotiated the write-off, and it has a contractual right of subrogation. Accordingly, evidence of the collateral benefits may not be introduced. It’s not a very difficult question.
{¶ 21} The court of appeals summed it up even more quickly than I have: “It is undisputed that this case arose after the enactment of R.C. 2315.20. It is further undisputed that the source of medical payments that [Mantón] attempted to introduce at trial were subject to a contractual right of subrogation. Accordingly, the application of the collateral source rule is controlled by R.C. 2315.20, and not
